NCT06466369View on ClinicalTrials.gov

Administration of Tadalafil in Patients With Benign Prostatic Hyperplasia

PHASE3CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

July 1, 2024

Study Completion Date

August 1, 2024

Conditions
BPH With Other Lower Urinary Tract Symptoms
Interventions
DRUG

Tadalafil

tadalafil 2.5 mg, 5 mg

Trial Locations (1)

Unknown

outpatient clinic of the urology department at AlZahraa University Hospital, Al-Azhar University, Faculty of Medicine for Girls., Cairo

All Listed Sponsors
lead

Al-Azhar University

OTHER

NCT06466369 - Administration of Tadalafil in Patients With Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter